http://www.npr.org/blogs/health/2012/04/25/151387672/evidence-mounts-that-diet-exercise-help-survivors-cut-cancer-risk?ft=1&f=1128&sc=tw

Identifying the 10 subtypes means patients in the future will know more exactly which type of breast cancer they have and, as more targeted drugs are developed, they should receive more effective or personalized medicines, said Julia Wilson, head of research information at Breakthrough Breast Cancer.

The findings by researchers in the U.K. and Canada will eventually enable doctors to better predict survival times in women with the disease and tailor the most appropriate treatment to their type of tumor, said Carlos Caldas, one of the authors and the chairman of cancer medicine at the University of Cambridge in England.

The study results should spur drugmakers to develop more drugs targeting tyrosine kinases, phosphatases and chromatin modifiers as possible treatments for the newly identified subtypes of breast cancer, Caldas said. http://www.businessweek.com/news/2012-04-18/doctors-redefine-breast-cancer-into-10-subtypes-in-study

In a study suggesting that red wine might be the next big thing in breast cancer prevention, a study has found that women who drank just under two servings of red wine daily experienced hormonal changes that mimic the effects of a drug used to prevent malignant breast tumors from coming back.

The study, published Friday in the Journal of Women’s Health, found that consuming the same amount of white wine did not have the same effect in premenopausal women participating in the study.

The authors asserted this was the first rigorous study to find that red wine is a “nutritional aromatase inhibitor in healthy premenopausal women.” Another study has found that women who drank more red wine showed less breast density on mammograms–an emerging marker for breast cancer risk– than those who drank other forms of alcohol.

http://www.latimes.com/health/boostershots/la-heb-breast-cancer-red-wine-study-says-20120106,0,2119902.story

2 p.m. Sunday Jan. 15 at the Ridgewood Racquet Club, 249 Ackerman Ave., Ridgewood.  Dr. Rosalyn Stahl,  Associate Director of Pathology and the Director of the High Risk Breast Cancer Program at Englewood Hospital, will talk about understanding  pathology reports and explain individual reports.  Dr. Stahl is an advocate for patients understanding their tests and taking control of their health care decisions. The program is presented by Tennis for Life, a non-profit support group which welcomes people in any phase of the breast cancer experience to free indoor tennis lessons and matches to improve their quality of life. Free. 201 894-3232 or yoyojanet@aol.com